SEPN
Septerna, Inc.
Septerna, Inc. (SEPN) has 7 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 17, 2026.
The most active filer is Chief People Officer Shaikhly Samira with 4 filings. Insiders have net sold $1.6M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Jeffrey T. Finer
- Employees:75
- HQ:South San Francisco, CA, US
- IPO:2024-10-25
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$1.5B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Bhatt ElizabethFirst filing | President and COO | Sale | 4,000 | $136K | Jul 17 | SEC ↗ |
| SVP, Drug Discovery | Sale | 3,333 | $115K | Jul 2 | SEC ↗ | |
| Chief People Officer | Sale | 2,178 | $77K | Jun 30 | SEC ↗ | |
Long Daniel D.First filing | SVP, Drug Discovery | Sale | 15,000 | $533K | Jun 24 | SEC ↗ |
| Chief People Officer | Sale | 6,250 | $219K | Jun 17 | SEC ↗ | |
| Chief People Officer | Sale | 5,935 | $172K | Jun 3 | SEC ↗ | |
Shaikhly SamiraFirst filing | Chief People Officer | Sale | 11,798 | $355K | May 28 | SEC ↗ |
Related companies
Septerna, Inc. is in the Healthcare sector.